Your browser doesn't support javascript.
loading
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care.
Carr, Matthew J; Wright, Alison K; Leelarathna, Lalantha; Thabit, Hood; Milne, Nicola; Kanumilli, Naresh; Ashcroft, Darren M; Rutter, Martin K.
Afiliação
  • Carr MJ; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester, UK matthew.carr@manchester.ac.uk.
  • Wright AK; NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK.
  • Leelarathna L; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester, UK.
  • Thabit H; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Milne N; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Kanumilli N; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Ashcroft DM; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Rutter MK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
BMJ Qual Saf ; 31(7): 503-514, 2022 07.
Article em En | MEDLINE | ID: mdl-34642228
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Qual Saf Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Qual Saf Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido